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Abstract
Background: In sub-Saharan Africa, non-typhoidal Salmonella (NTS) are emerging as a prominent cause of invasive disease
(bacteremia and focal infections such as meningitis) in infants and young children. Importantly, including data from Mali,
three serovars, Salmonella enterica serovar Typhimurium, Salmonella Enteritidis and Salmonella Dublin, account for the
majority of non-typhoidal Salmonella isolated from these patients.
Methods: We have extended a previously developed series of polymerase chain reactions (PCRs) based on O serogrouping
and H typing to identify Salmonella Typhimurium and variants (mostly I 4,[5],12:i:-), Salmonella Enteritidis and Salmonella
Dublin. We also designed primers to detect Salmonella Stanleyville, a serovar found in West Africa. Another PCR was used to
differentiate diphasic Salmonella Typhimurium and monophasic Salmonella Typhimurium from other O serogroup B, H:i
serovars. We used these PCRs to blind-test 327 Salmonella serogroup B and D isolates that were obtained from the blood
cultures of febrile patients in Bamako, Mali.
Principal Findings: We have shown that when used in conjunction with our previously described O-serogrouping PCR, our
PCRs are 100% sensitive and specific in identifying Salmonella Typhimurium and variants, Salmonella Enteritidis, Salmonella
Dublin and Salmonella Stanleyville. When we attempted to differentiate 171 Salmonella Typhimurium (I 4,[ 5],12:i:1,2) strains
from 52 monophasic Salmonella Typhimurium (I 4,[5],12:i:-) strains, we were able to correctly identify 170 of the Salmonella
Typhimurium and 51 of the Salmonella I 4,[5],12:i:- strains.
Conclusion: We have described a simple yet effective PCR method to support surveillance of the incidence of invasive
disease caused by NTS in developing countries.
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Introduction
In industrialized countries, non-typhoidal Salmonella (NTS)
constitute a well recognized public health problem that in healthy
subjects is overwhelmingly encountered clinically as self-limited
gastroenteritis [1,2]. In immunocompromised and debilitated
hosts, NTS can become invasive, leading to bacteremia, sepsis
and focal infections (e.g., meningitis) [2,3]. Among infants less than
three months of age who become infected with NTS in
industrialized countries, invasiveness is also occasionally observed,
resulting in bacteremia and focal infections [4].
Interestingly, whereas systematic blood culture-based surveil-
lance of febrile pediatric patients in Asia has clearly highlighted the
high incidence of bacteremia associated with Salmonella enterica
serovars Typhi and Paratyphi A in children residing in crowded
urban settings [5–7], isolation of NTS has not been common. In
striking contrast, systematic blood culture-based surveillance and
clinical studies of hospitalized and ambulatory pediatric patients
,60 months of age with fever or focal infections in sub-Saharan
Africa have documented the important role of NTS as invasive
bacterial pathogens [8–17]. NTS constituted one of the three most
common invasive bacterial pathogens in all these studies.
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murium variants) and Salmonella Enteritidis have been reported to
account for 79–95% of all bacteremic non-typhoidal Salmonella
infections in sub-Saharan Africa [9,11–13,15,16,18,19]. Salmonella
Dublin has been associated with a few percent of cases in some
studies [12,13] but with a more substantial proportion in Mali
[18], where a fourth serovar, Salmonella Stanleyville, also accounted
for a notable proportion of all isolates [18], bringing the
cumulative total to .95% of all strains.
We previously developed a multiplex polymerase chain reaction
(PCR)-based approach to identify the three main pathogens
responsible for typhoid (Salmonella Typhi) and paratyphoid
(Salmonella Paratyphi A and Salmonella Paratyphi B) fevers [18].
Three sequential PCRs identify strains of Salmonella serogroups A,
B or D (and Vi positive or negative); strains that express Phase 1
flagellar (H) antigen types H:a, H:b or H:d; and strains incapable
of fermenting d-tartrate (d-T). By means of this PCR technology,
Salmonella Typhi (O serogroup D, Vi
+; H:d), Salmonella Paratyphi A
(O serogroup A; H:a) and Salmonella Paratyphi B (O serogroup B;
H:b; d-T non-fermenter) strains were identified with 100%
sensitivity and 100% specificity.
Classical Salmonella serotyping methods identified the serovars of
336 NTS isolates from blood cultures of febrile children ,16 years
of age in Bamako, Mali, obtained in the course of systematic
surveillance of children admitted to hospital or seen in the
Emergency Department with fever or invasive infection syndromes
[20–22]. Salmonella Typhimurium and ‘‘variants’’ (mainly I
4,[5],12:i:-), Salmonella Dublin, Salmonella Enteritidis and Salmonella
Stanleyvillewerethe mostcommonlyisolatedNTS[18].Herein,we
describe PCRs that when used in conjunction with the O
serogrouping PCR described by Levy et al. [18] can identify
Salmonella Typhimurium and variants (O serogroup B; H:i),
Salmonella Enteritidis (O serogroup D, Vi
-; H:g,m), Salmonella Dublin
(O serogroup D, Vi
+ or Vi
-; H:g,p) and Salmonella Stanleyville (O
serogroup B; H:z4,z23) with 100% sensitivity and 100% specificity.
We anticipate that this methodology will be useful in reference
laboratories and major clinical microbiology laboratories to identify
Salmonella isolated from blood and other sterile sites in developing
countries where robust PCR-based typing techniques are becoming
increasingly popular and because high quality H typing sera are
difficult to obtain, expensive and technically demanding to use.
Methods
Ethics statement
The surveillance protocol and consent form were reviewed by
the Ethics Committee of the Faculte ´d eM e ´decine, Pharmacie et
Odonto-Stomatologie, Universite ´ de Bamako, and by the
Institutional Review Board of the University of Maryland,
Baltimore. For any patient eligible for laboratory surveillance to
detect invasive bacterial disease, informed consent was obtained
prior to their enrollment; ,95% of eligible subjects agreed to
participate. Since the literacy rate in Bamako is ,30%, as is
customary practice for CVD-Mali clinical studies [20–22], the
consent form was translated into Bambara and several other local
languages and the translations recorded on audiotape [20]. CVD-
Mali personnel explain the study, including the objectives and risks
and benefits associated with participation. The audiotaped version
of the consent form is then played and any questions posed are
answered. Once the parent or patient has had all questions
answered and agrees to participate, this is documented on a
printed consent form written in French. If the participant is
illiterate, a witness who is present throughout the consent
procedure completes the necessary portions and signs the consent
form; the parent/participant marks the consent form (either
fingerprint or other notation). If the person is literate, then he/she
may read and sign the consent form. This standard method of
obtaining consent practiced by CVD-Mali was approved by ethics
commitees in Mali and at the University of Maryland.
Systematic surveillance for invasive bacterial infections
Since July 2002, clinical staff of the Centre pour le De ´veloppe-
ment des Vaccins du Mali (CVD-Mali) and l’Ho ˆpital Gabriel Toure ´
(HGT) have been conducting systematic surveillance to detect
invasive bacterial disease among hospitalized children ,16 years of
age [20–22]. Age-eligible children presenting to the emergency
department with fever ($39uC) or focal clinical findings suggestive
of invasive bacterial infection (meningitis, septic arthritis, etc.) and
requiring hospitalization are referred to CVD-Mali staff by the
evaluating clinicians. A CVD-Mali physician obtains informed
consent, records clinical and epidemiologic data, and obtains blood
(and other relevant fluids) for culture in the HGT Clinical
Bacteriology Laboratory. The child’s clinician is promptly notified
when a culture yields a bacterial pathogen.
Salmonella strains
Salmonella Typhimurium strain 81.23500, Salmonella Enteritidis
strain CVD SE and Salmonella Dublin strain 06-0707 were used to
develop the multiplex PCR. Twenty-four control strains which
came from the Salmonella Reference Laboratory of the Centers for
Disease Control and Prevention (CDC), Atlanta, GA or the Center
for Vaccine Development, Baltimore, MD have previously been
described [18]. These strains were Salmonella serovars of various O
serogroups (B, C1, C2, D, E1, O28 and O38) and H types (b, c, d,
h, i, g, k, l, m, p, s, t, v, y, z10 and z29). Nine O serogroup B, Phase
1 flagella antigen H:i reference strains from the CDC were used to
Author Summary
The genus Salmonella has more than 2500 serological
variants (serovars), such as Salmonella enterica serovar
Typhi and Salmonella Paratyphi A and B, that cause,
respectively, typhoid and paratyphoid fevers (enteric
fevers), and a large number of non-typhoidal Salmonella
(NTS) serovars that cause gastroenteritis in healthy hosts.
In young infants, the elderly and immunocompromised
hosts, NTS can cause severe, fatal invasive disease. Multiple
studies of pediatric patients in sub-Saharan Africa have
documented the important role of NTS, in particular
Salmonella Typhimurium and Salmonella Enteritidis (and to
a lesser degree Salmonella Dublin), as invasive bacterial
pathogens. Salmonella spp. are isolated from blood and
identified by standard microbiological techniques and the
serovar is ascertained by agglutination with commercial
antisera. PCR-based typing techniques are becoming
increasingly popular in developing countries, in part
because high quality typing sera are difficult to obtain
and expensive and H serotyping is technically difficult. We
have developed a series of polymerase chain reactions
(PCRs) to identify Salmonella Typhimurium and variants,
Salmonella Enteritidis and Salmonella Dublin. We success-
fully identified 327 Salmonella isolates using our multiplex
PCR. We also designed primers to detect Salmonella
Stanleyville, a serovar found in West Africa. Another PCR
generally differentiated diphasic Salmonella Typhimurium
and monophasic Salmonella Typhimurium variant strains
from other closely related strains. The PCRs described here
will enable more laboratories in developing countries to
serotype NTS that have been isolated from blood.
PCR for Invasive Non-typhoidal Salmonella
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ium and I 4,[5],12:i:- (Table 1). The NTS test strains consist of 327
Salmonella serogroup B and D isolates that were originally obtained
from the blood cultures of febrile patients at l’Ho ˆpital Gabriel
Toure ´ in Bamako, Mali. These strains were identified by
conventional microbiological and classical serotyping methods by
the CVD and CDC, as previously described [18]; 69 isolates were
O serogroup D, including 37 Salmonella Dublin and 32 Salmonella
Enteritidis, and 258 isolates were O serogroup B.
Primers
Detection of Salmonella Typhimurium and variants,
Salmonella Enteritidis and Salmonella Dublin (and later
Salmonella Stanleyville). This primer mix contained the
following primers: H-for, a primer sequence common to fliC of
both Salmonella Typhimurium (H:i) and Salmonella Dublin (H:g,p);
Hi, unique to fliC of H:i organisms; Hgp, unique to fliC of H:g,p
organisms; sdfF and sdfR, which amplify Sdf I, a fragment of DNA
unique to Salmonella Enteritidis; and 16SF and DG74, universal
bacterial 16S rRNA gene primers that were included to ensure
that DNA was added (Table 2).
Primer Hgp was designed by performing Clustal W alignments
between fliC nucleotide sequences deposited in GenBank (three
Salmonella Enteritidis sequences, DQ095560, AY649709 and
AY649742; one Salmonella Dublin sequence, AY649712). The fliC
alleles of Salmonella Enteritidis (fliC-g,m) and Salmonella Dublin (fliC-
g,p) are very similar, as they are both G complex alleles that are
almost identical to one another [23]. The nucleotide sequence of
fliC-g,p, to which primer Hgp binds, differs from fliC-g,m by two
nucleotides. The Hgp primer was therefore designed such that one
of these mismatches was at the 39 end of Hgp (fliC-g,p has a ‘T’
whereas fliC-g,m has a ‘C’).
In a later step, primers to detect fliC of Salmonella Stanleyville
(H:z4,z23) were added to the primer mix. Primers Hz4,z23F and
Hz4,z23R were designed to amplify a 427-bp fragment of fliC-
z4,z23 (based on GenBank accession no. AY649736).
Differentiation of diphasic Salmonella Typhimurium and
monophasic Salmonella Typhimurium from other H:i
serovars. We combined published primers in a PCR to
discriminate between Salmonella Typhimurium (I 4,[5],12:i:1,2)
and the monophasic serovar I 4,[5],12:i:- and other O serogroup
B, H:i serovars. To accomplish this, we used a primer mix
containing primers FFLIB and RFLIA, which amplify the fliB-fliA
intergenic region, and primers Sense-59 and Antisense-83, which
amplify the Phase 2 (fljB) flagellar gene.
DNA extraction and PCR
PCR was performed in 16 PCR buffer, 3.5 mM MgCl2,
0.2 mM of dNTPs and 0.2 U of Invitrogen Taq DNA polymerase
(final volume of 25 ml) in an Eppendorf MastercyclerH. The primer
mixes contained primers at a concentration of 5 mM each (final
concentration of 0.2 mM) except for FFLIB and RFLIA that were
used at a concentration of 10 mM each and the positive control
primers (16SF and DG74) that were used at a concentration of
2.5 mM each. For each PCR reaction, 1.0 ml of primer mix was
used. Crude DNA was prepared by suspending 3 colonies in
100 ml water and boiling for 10 min followed by centrifugation at
16,0006g for 30 sec and purified DNA was prepared using a
GNOME DNA kit (QBIOgene, Irvine, CA) according to the
manufacturer’s instructions, and 5 ml of DNA was used in each
PCR. The cycling parameters of the multiplex PCR that detects
H:i, H:g,p and Sdf I involved denaturation at 95uC for 2 min,
followed by 25 cycles comprised of heating to 95uC for 30 sec,
64uC for 30 sec and 72uC for 15 sec, and a final step of 72uC for
5 min. The cycling parameters of the PCR that discriminates
between Salmonella Typhimurium and I 4,[5],12:i:- involved
denaturation at 95uC for 2 min, followed by 25 cycles of 95uC
for 30 sec, 64uC for 30 sec and 72uC for 1.5 min, and a final step
of 72uC for 5 min. PCR products were separated on 2% (w/v)
agarose gels, stained with ethidium bromide and visualized using a
UV transilluminator.
Results
A multiplex PCR to detect Salmonella Typhimurium and
monophasic variants, Salmonella Enteritidis and
Salmonella Dublin
Figure 1 shows that the primers within the multiplex PCR were
able to clearly identify the appropriate NTS alleles. A 779-bp
Table 1. Nine reference strains of Salmonella consisting of
serovars that belong to O group B and that possess Phase 1 H
flagella antigen ‘‘i’’.
Strain Serovar O antigens
Phase 2 H
flagella
antigen(s)
CDC 443 Gloucester 1,4,12,(27) l,w
CDC 513 Agama 4,12 1,6
CDC 1045 Lagos 1,4,12 1,5
CDC 1638 Tsevie 4,12 e,n,z15
CDC 1855 Lagos 1,4,12 1,5
CDC 2322 Farsta 4,12 e,n,x
CDC 2419 Tumodi 1,4,12 z6
CDC 07-0794 I 4,[5],12:i:- 4,[5],12 –
CDC 07-0972 I 4,[5],12:i:- 4,[5],12 –
doi:10.1371/journal.pntd.0000621.t001
Table 2. Primers used in this study.
Primer Sequence (59 to 39)
Amplicon
(bp) Reference
H-for ACTCAGGCTTCCCGTAACGC [18]
Hgp ATTAACATCCGCCGCGCCAA 779 This study
Hi ATAGCCATTTACCAGTTCC 551 [37]
Hz4,z23F TTTGTCAAAGATGTTACTGCG 427 This study
Hz4,z23R AGGTTAGTGATGGCAGATTC This study
sdfF TGTGTTTTATCTGATGCAAGAGG 333 [27]
sdfR CGTTCTTCTGGTACTTACGATGAC [27]
16SF AATACGTTCCCGGGCCTTG 167 Based on
universal
bacterial
probe RDR245
in [47]
DG74 AGGAGGTGATCCAACCGCA [47]
Sense-59 CAACAACAACCTGCAGCGTGTGCG 1389 [26]
Antisense-83 GCCATATTTCAGCCTCTCGCCCG [26]
FFLIB CTGGCGACGATCTGTCGATG 250 or 1000 [24]
RFLIA GCGGTATACAGTGAATTCAC [24]
doi:10.1371/journal.pntd.0000621.t002
PCR for Invasive Non-typhoidal Salmonella
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product was amplified from Salmonella Typhimurium (fliC-i) and a
333-bp product was amplified from Salmonella Enteritidis (Sdf I).
The internal positive control primers (universal 16S rRNA gene
primers) amplified a 167-bp product from each strain.
Initial validation of the multiplex PCR assay
To preliminarily assess the specificity of the multiplex PCR
assay, we tested 24 control Salmonella strains consisting of a range
of serovars (previously described in [18]) in a blinded fashion
(Figure 2). The multiplex PCR correctly identified Salmonella
Typhimurium and Salmonella Cotham as H:i, Salmonella Dublin as
H:g,p and Salmonella Enteritidis as containing Sdf I (Figure 2).
Faint products of the size of Sdf I were observed for Salmonella
Meleagridis and Salmonella Livingstone. However, Salmonella
Meleagridis is O serogroup E1 and Salmonella Livingstone is O
serogroup C1, so when also tested by our previously described O
serogrouping PCR [18], these serovars would not be mistaken as
Salmonella Enteritidis. The same is true for Salmonella Cotham,
which although it possesses fliC-i, is not O serogroup B and would
not be mistaken as Salmonella Typhimurium. Therefore, the new
multiplex PCR was sensitive in terms of its ability to identify
serovar Cotham as H:i and was specific, when combined with the
O-serogrouping PCR, in showing that the strain was not serovar
Typhimurium. We also blind-tested a sample of Salmonella Typhi
and Salmonella Paratyphi A and B strains to ensure that the PCR
would not detect these strains. The multiplex PCR correctly
identified fliC-i of six Salmonella Typhimurium, Sdf I of four
Salmonella Enteritidis, and fliC-g,p of five Salmonella Dublin strains
but only the 16S rRNA gene was amplified from five strains each
of serovars Typhi, Paratyphi A and Paratyphi B (data not shown).
Analysis of 327 Salmonella seroroup B and D clinical
isolates from Mali
We blind-tested 69 non-Typhi serogroup D Salmonella and 258
serogroup B strains that were originally obtained from the blood
cultures of febrile patients at l’Ho ˆpital Gabriel Toure ´ in Bamako,
Figure 1. Multiplex PCR to identify Salmonella Typhimurium
and variants, Salmonella Enteritidis and Salmonella Dublin.
Lanes: 1, 1 kb ladder (Invitrogen); 2, Salmonella Typhimurium
81.23500; 3, Salmonella Enteritidis CVD SE; and 4, Salmonella Dublin
06-0707.
doi:10.1371/journal.pntd.0000621.g001
Figure 2. Blinded screening of 24 control strains by the fliC-i/fliC-gp/Sdf I multiplex PCR. Reference strains consisted of one representative
each of Salmonella Typhimurium, Salmonella Enteritidis and Salmonella Dublin and a range of negative control Salmonella strains of various serovars.
PCR controls consisted of Salmonella Typhimurium 81.23500, Salmonella Enteritidis CVD SE, Salmonella Dublin 06-0707.
doi:10.1371/journal.pntd.0000621.g002
PCR for Invasive Non-typhoidal Salmonella
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Typhimurium (I 4,[5],12:i:1,2) and variants (monophasic I
4,[5],12:i:- and non-motile (NM) I 4,[5],12:NM), Salmonella
Enteritidis and Salmonella Dublin. This PCR was performed in
parallel to serotyping. We correctly identified all the serogroup D
isolates (37 Salmonella Dublin and 32 Salmonella Enteritidis) and all
232 Salmonella Typhimurium and variant strains (Table 3). If the
Salmonella Typhimurium-like strains (i.e., I 4,[5],12:i:- and I
4,[5],12:NM) are included in the target group then the PCR is
100% sensitive and 100% specific in identifying Salmonella
Typhimurium, Salmonella Enteritidis, Salmonella Dublin and Salmo-
nella Typhimurium-like organisms. The remaining 26 serogroup B
isolates were negative for the tested targets.
Discrimination between Salmonella Typhimurium and I
4,[5],12:i:-
During the course of this study, we decided to determine the
prevalence of I 4,[5],12:i:- in Mali. Levy et al. [18] identified 220
Salmonella Typhimurium, four I 4,[5],12:i:- and eight I
4,[5],12:NM strains. However, in this previous study, Phase 2
flagella typing was not performed on all of the strains. We re-
examined the 220 Salmonella O serogroup B, H:i isolates that had
been previously been presumptively identified as Salmonella
Typhimurium and used classical methods (i.e., sera against the
Phase 2 H1,2 flagella) to determine that 48 isolates were in fact I
4,[5],12:i:- (bringing the total number of isolates of this serovar to
52) and one isolate was I 4,[5],12:NM (bringing the total number
of isolates of this serovar to nine). The remaining 171 strains were
confirmed as Salmonella Typhimurium.
We have combined previously described primers in a PCR to
discriminate between Salmonella Typhimurium and I 4,[5],12:i:-.
Primers FFLIB and RFLIA amplify the fliB-fliA intergenic region
of the flagellin gene cluster [24]. Salmonella Typhimurium strains
possess an IS200 fragment in this region [25]. Burnens et al. [25]
showed that 21 of 23 isolates of Salmonella Typhimurium and none
of 85 isolates of 37 other Salmonella serovars contained IS200 in this
region. Primers FFLIB and RFLIA have been reported to amplify
a 1-kb product from Salmonella Typhimurium and I 4,[5],12:i:-
strains and a 250-bp product from all other serovars [24].
However, when validating these primers, we found that a 1-kb
fragment was amplified from Salmonella Farsta (not tested by
Echeita et al. [24]) suggesting that this serovar also possesses IS200
in the fliB-fliA intergenic region (Figure 3).
Primers Sense-59 and Antisense-83 amplify the fljB allele [26].
Primer Sense-59 binds at position 258 and primer Antisense-83
binds at position +100 of the 59-39 consensus fljB1,2 sequence.
These primers amplify a 1389-bp product from strains that possess
a Phase 2 flagellar antigen and no product from strains that lack a
Phase 2 flagellar antigen such as I 4,[5],12:i:-. As shown in
Figure 3, the PCR was able to discriminate between Salmonella
Typhimurium and I 4,[5],12:i:- strains and other serogroup B, H:i
serovars except Salmonella Farsta.
We tested all the Salmonella Typhimurium, I 4,[5],12:i:- and I
4,[5],12:NM strains identified in Mali and found that 170 of 171
Salmonella Typhimurium strains were correctly identified (i.e.,
possessed a 1-kb fliB-fliA intergenic region product and fljB1,2), and
51 of 52 I 4,[5],12:i:- strains were correctly identified (i.e.,
possessed a 1-kb fliB-fliA intergenic region product and lacked
fljB1,2) (Table 4). The nine I 4,[5],12:NM strains produced mixed
results in that all nine strains produced a 1-kb fliB-fliA intergenic
region product but three strains possessed fljB1,2.
Detection of Salmonella Stanleyville
Since Salmonella Stanleyville was found to be fairly common
among the Mali NTS isolates, we added primers to detect fliC-
z4,z23 of Salmonella Stanleyville to the multiplex PCR containing
primers H-for, Hi, sdfF, sdfR, 16SF and DG74. The primers were
first tested on Salmonella Stanleyville by themselves and produced a
427-bp amplicon. The fliC-z4,z23 primers were then added to the
multiplex primer mix and PCR was performed (using the
previously optimized conditions) on all 26 Salmonella Stanleyville
strains, and a sample of 10 Salmonella Typhimurium, 10 Salmonella
Dublin and 11 Salmonella Enteritidis strains. Correct amplicons
were observed for all the strains tested. Figure 4 shows amplicons
from a sample of three Salmonella Stanleyville strains and the
control Salmonella Typhimurium, Salmonella Enteritidis and Salmo-
nella Dublin strains.
Discussion
We have combined published primers and new primers in a
multiplex PCR that, following the application of a previously
described O serogrouping multiplex PCR [18], can identify
Salmonella Typhimurium (and variants), Salmonella Enteritidis,
Salmonella Dublin and Salmonella Stanleyville. Detection of
Salmonella Typhimurium, Salmonella Dublin and Salmonella Stanley-
ville is based on amplification of the respective fliC alleles. We were
unable to design primers to detect fliC-g,m of Salmonella Enteritidis
due to the high nucleotide identity between fliC-g,m and fliC-g,p
(of Salmonella Dublin). We therefore used primers to detect
‘‘Salmonella difference fragment I’’ (Sdf I), a segment of Salmonella
Enteritidis DNA that was reported to be absent from 73 non-
Enteritidis Salmonella enterica isolates comprising 34 different
serovars as determined by PCR [27]. We confirmed the utility
of Sdf I, with the exception of serovars Meleagridis and
Livingstone. We found that Salmonella Livingstone yielded a weak
PCR product using the same Sdf I primers that were previously
reported [27]. The disparity could be due to a difference in the
Table 3. Detection of Salmonella Typhimurium and variants, Salmonella Enteritidis and Salmonella Dublin by multiplex PCR among
69 non-Typhi Group D Salmonella and 258 Group B Salmonella isolated from blood cultures of febrile patients in Bamako, Mali.
O Group Serovar No. of isolates Multiplex PCR
fliC-i fliC-g,p Sdf I
D Dublin 37 0 37 0
Enteritidis 32 0 0 32
B Typhimurium and Typhimurium variants 232 232 0 0
Stanleyville 26 0 0 0
doi:10.1371/journal.pntd.0000621.t003
PCR for Invasive Non-typhoidal Salmonella
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tions were used).
From the epidemiologic and public health perspective, being
able to detect strains that are genetically similar to Salmonella
Typhimurium yet that constitute distinct serovars (i.e., I 4,[5],12:i:-
and I 4,[5],12:NM) is important (e.g., for outbreak investigations).
In the USA and Europe such strains are increasingly being
reported [28–30]. In Spain, I 4,[5],12:i:- was the fourth most
commonly isolated Salmonella serovar from humans from 1998–
1999 [29] and several studies suggest that this monophasic serovar
is a variant of Salmonella Typhimurium [24,31–33]. The PCR that
we have described can generally discriminate the diphasic
Salmonella Typhimurium serovar (I 4,[5],12:i:1,2) from monophasic
(I 4,[5],12:i:-) variants. Only one Salmonella Typhimurium was
misidentified as I 4,[5],12:i:- and vice versa. It is possible that our
PCR will not be able to detect some serologically monophasic I
4,[5],12:i- strains as lack of Phase 2 flagellar antigen expression
can be due to a variety of mechanisms ranging from point
mutations to partial or complete deletions in fljB1,2 and adjacent
genes. Additionally, if there is a deletion in the first 250 bp of
fljB1,2, the primers we have chosen will not identify the strain as I
4,[5],12:i-. Furthermore, our PCR scheme cannot differentiate
between Salmonella Typhimurium and Salmonella Farsta. However,
in practical terms, this is unlikely to pose a problem as Salmonella
Farsta is extremely rare.
One small set of strains where our PCR gives differing results
from traditional serological methods are Salmonella Typhimurium-
like non-motile variants (I 4,[5],12:NM). Notably, all nine Malian
strains identified by serotyping methods as I 4,[5],12:NM were
found to possess the fliC-i allele and three of the strains also
possessed the fljB1,2 gene. Two quite distinct explanations can
account for these observations. One is that in some strains lack of
motility is not due to loss of flagellar genes but rather to other
factors (e.g., regulation) that keep expression turned off. Alterna-
tively, it may be that our genetic identification of these strains is
correct and that the failure to detect flagella phenotypically is
merely a consequence of not knowing how to grow the bacteria
under conditions optimal for expression of those flagella. We
assume that the I 4,[5],12:NM strains from Mali are Salmonella
Figure 3. Differentiation of diphasic Salmonella Typhimurium and monophasic Salmonella Typhimurium from other H:i serovars. The
PCR to discriminate between Salmonella Typhimurium and I 4,[5],12:i:- strains was validated using nine reference Salmonella O group B, H:i isolates of
various serovars.
doi:10.1371/journal.pntd.0000621.g003
Table 4. Detection of Salmonella Typhimurium, I 4,[5],12:i:-
and I 4,[5],12:NM by PCR among 232 Group B Salmonella that
possess fliC-i.
Serovar
No. of
isolates Multiplex PCR
fliB-fliA intergenic
region - 250 bp
fliB-fliA intergenic
region - 1 kb fljB
Typhimurium 171 0 171 170
I 4,[5],12:i:- 52 0 52 1
I 4,[5],12:NM
a 90 9 3
aNM, non-motile.
doi:10.1371/journal.pntd.0000621.t004
Figure 4. Detection of Salmonella Stanleyville. Amplification of fliC
from 3 Salmonella Stanleyville strains from Mali and Salmonella
Typhimurium 81.23500, Salmonella Enteritidis CVD SE and Salmonella
Dublin 06-0707 following the addition of Hz4,z23 primers to the fliC-i/
fliC-gp/Sdf I multiplex PCR mix.
doi:10.1371/journal.pntd.0000621.g004
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fliA intergenic region. It is also possible, albeit unlikely, that they
could be the very rarely isolated Salmonella Farsta.
Soyer et al. [34] have reported that there are at least two
common clones of I 4,[5],12:i:- with different genomic deletions
(an ‘American’ deletion genotype and a ‘Spanish’ deletion
genotype). Both I 4,[5],12:i:- clones completely lack fljB and fljA.
Preliminary analysis of the deletion using a variety of primers that
amplify different sections of the fljB1,2 gene indicates that the I
4,[5],12:i:- strains from Mali appear to possess the 39 end of fljB
Table 5. Salmonella serovars identified by the PCRs described in this report and in Levy et al. [18].
OG r o u p V i
Phase 1 H
flagella Sdf I
fliB-fliA intergenic
region fljB
d-tartrate
fermentation Serovar
Typhoidal
serovars
A – a – 250 bp + ND
a Paratyphi A
B – b – 250 bp + – Paratyphi B sensu stricto
D + d or j – 250 bp – ND Typhi
Non-typhoidal
serovars
B– bN D N D N D + Paratyphi B Java
B– i – 1 k b + ND Typhimurium and Farsta
B – i – 1 kb – ND I 4,[5],12:i:-
B – z4,z23 – 250 bp – ND Stanleyville
D +/– g,p – 250 bp – ND Dublin
D– + 250 bp – ND Enteritidis
aND, not determined.
doi:10.1371/journal.pntd.0000621.t005
Figure 5. The steps used to identify typhoidal and non-typhoidal serovars of Salmonella isolated from blood.
doi:10.1371/journal.pntd.0000621.g005
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Sense-59 binding site) has been deleted at the 59 end (data not
shown). This suggests that these strains are genetically different
from both the Spanish and American I 4,[5],12:i:- isolates. We are
sequencing the deletion in several Malian I 4,[5],12:i- strains to
determine the exact deletion. It will be interesting to see whether I
4,[5],12:i:- strains from other African countries are genetically
similar to the Malian strains.
Several other DNA-based Salmonella typing methods have been
described [35–41]. However, some of these do not identify the
breadth of enteric fever and NTS serovars of our multistep,
multiplex PCR or fail to include an internal positive control. An O
serogroup-specific Bio-Plex assay to detect serogroups B, C1, C2,
D, E and O13 and serovar Paratyphi A [42] and a DNA sequence-
based approach to serotyping have also been described [43].
However, these methods require greater financial and technical
resources over those required for our method. Our PCRs are novel
because they use as few primers as possible to identify the most
common non-typhoidal Salmonella serovars isolated from blood and
other invasive sites in sub-Saharan Africa, including Salmonella
Typhimurium (and several variants), Salmonella Enteritidis, Salmo-
nella Dublin and Salmonella Stanleyville. Since the late 1980s, the
majority (85 to 95%) of NTS associated with invasive disease in
sub-Saharan Africa belong to these serovars [9,11–13,15,16,18,19].
Therefore, we do not believe that there is a need for multiplex
PCRs that detect more serovars unless the epidemiologic picture
changes. We have tried to keep the PCRs as simple as possible so
that they can be performed easily and the results interpreted
correctly in laboratories in Africa that may be new to PCR. If a
large outbreak or otherwise frequent isolation occurred of a serovar
not presently recognized or contained within our multiplex, this
serovar would not be identifiable using our PCR and would have to
be identified in a reference laboratory using antisera or by
molecular serotyping.
We are currently evaluating various PCR reagents that are
stable at room-temperature and can be readily obtained by
laboratories in Africa. Depending on the prevalence of certain
serovars in a given country, either typhoidal or non-typhoidal
Salmonella (or both) can be identified using our primer sets (Table 5
and Figure 5). For example, one may wish to test all Salmonella
isolates in the O serogrouping PCR, then screen serogroup A, B
and D Vi
+ strains using the first H typing multiplex PCR to
identify Salmonella Typhi, Salmonella Paratyphi A and Salmonella
Paratyphi B. The d-tartrate fermentation PCR can be performed
to differentiate Salmonella Paratyphi B sensu stricto strains from
Salmonella Paratyphi B Java. Any serogroup B isolates not identified
by the 1
st H typing PCR can be tested along with non-Typhi O
serogroup D strains in the second H typing/Sdf I multiplex PCR
to identify serovars Typhimurium (and related strains), Dublin
(which can be Vi
+ or Vi
- [44]), Enteritidis and Stanleyville. The O
serogroup B H:i strains can be tested using the Typhimurium/I
4,[5],12:i:- PCR to identify Salmonella Typhimurium and I
4,[5],12:i:-. It should be stressed that the O serogrouping PCR
described by Levy et al. [18] needs to be performed in conjunction
with the PCRs described here to ensure that Salmonella Enteritidis
and Salmonella Typhimurium are identified correctly and not
mistaken as Salmonella Meleagridis and Salmonella Livingstone; and
Salmonella Cotham, respectively.
The surveillance experience in Mali is the first to show that
Salmonella Dublin and Salmonella Stanleyville can constitute
important serovars associated with invasive non-typhoidal Salmo-
nella disease, along with Salmonella Typhimurium (and variants) and
Salmonella Enteritidis. Previously, Salmonella Dublin and Salmonella
Stanleyville were recovered only occasionally from blood cultures
of patients in Africa [12,13,45,46]. We thought it useful to be able
to detect these serovars by PCR in future surveillance studies in
Africa.
In conclusion, we have described a series of PCRs based on O
serogrouping and H typing that can identify the causative agents
of enteric fever (Salmonella Typhi and Salmonella Paratyphi A and
Salmonella Paratyphi B), the three most commonly isolated serovars
that cause invasive disease in young children in sub-Sahara
African (Salmonella Typhimurium [and Typhimurium-like], Salmo-
nella Enteritidis and Salmonella Dublin) and Salmonella Stanleyville,
an invasive pathogen that may be of regional importance in West
Africa.
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